- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/66 - Nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 333/66
Total number of patents in this class: 111
10-year publication summary
|
6
|
8
|
10
|
4
|
13
|
3
|
10
|
11
|
5
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10989 |
6 |
| Zhejiang Jingxin Pharmaceutical Co., Ltd. | 21 |
5 |
| Jacobio Pharmaceuticals Co., Ltd. | 98 |
4 |
| Shanghai Jingxin Biology & Pharmaceutical Co., Ltd. | 7 |
4 |
| BASF SE | 20675 |
3 |
| Janssen Pharmaceutica N.V. | 3437 |
3 |
| Curadev Pharma Pvt Ltd. | 21 |
3 |
| Merial, Inc. | 222 |
3 |
| Promega Corporation | 571 |
3 |
| Idemitsu Kosan Co., Ltd. | 4138 |
2 |
| Chugai Seiyaku Kabushiki Kaisha | 1325 |
2 |
| East China University of Science and Technology | 509 |
2 |
| Eli Lilly and Company | 3781 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 816 |
2 |
| UCB Pharma S.A. | 257 |
2 |
| Universite de Montreal | 342 |
2 |
| University of Iowa Research Foundation | 809 |
2 |
| H. Lundbeck A/S | 1187 |
2 |
| Agc, Inc. | 4663 |
2 |
| Janssen Biopharma, Inc. | 40 |
2 |
| Other owners | 55 |